Price to Book Value (P/BV)
since 2005
Calculation
Amgen Inc., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Stockholders’ equity1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2024 | 24.94 | = | 290.07 | ÷ | 11.63 | 11.63 | = | 6,232 | ÷ | 535,918,901 | |
| Feb 9, 2023 | 35.01 | = | 240.00 | ÷ | 6.86 | 6.86 | = | 3,661 | ÷ | 533,976,238 | |
| Feb 16, 2022 | 18.51 | = | 222.66 | ÷ | 12.03 | 12.03 | = | 6,700 | ÷ | 557,029,370 | |
| Feb 9, 2021 | 14.53 | = | 236.65 | ÷ | 16.29 | 16.29 | = | 9,409 | ÷ | 577,566,383 | |
| Feb 12, 2020 | 13.84 | = | 227.00 | ÷ | 16.40 | 16.40 | = | 9,673 | ÷ | 589,806,819 | |
| Feb 13, 2019 | 9.41 | = | 188.98 | ÷ | 20.09 | 20.09 | = | 12,500 | ÷ | 622,278,034 | |
| Feb 13, 2018 | 5.02 | = | 175.94 | ÷ | 35.03 | 35.03 | = | 25,241 | ÷ | 720,562,246 | |
| Feb 14, 2017 | 4.14 | = | 168.05 | ÷ | 40.57 | 40.57 | = | 29,875 | ÷ | 736,452,791 | |
| Feb 16, 2016 | 3.94 | = | 147.15 | ÷ | 37.34 | 37.34 | = | 28,083 | ÷ | 752,091,038 | |
| Feb 19, 2015 | 4.59 | = | 156.05 | ÷ | 33.97 | 33.97 | = | 25,778 | ÷ | 758,861,306 | |
| Feb 24, 2014 | 4.30 | = | 125.79 | ÷ | 29.27 | 29.27 | = | 22,096 | ÷ | 755,007,290 | |
| Feb 27, 2013 | 3.57 | = | 91.03 | ÷ | 25.47 | 25.47 | = | 19,060 | ÷ | 748,430,018 | |
| Feb 29, 2012 | 2.83 | = | 68.01 | ÷ | 24.04 | 24.04 | = | 19,029 | ÷ | 791,432,134 | |
| Feb 25, 2011 | 2.04 | = | 52.26 | ÷ | 25.68 | 25.68 | = | 23,944 | ÷ | 932,452,902 | |
| Mar 1, 2010 | 2.46 | = | 56.90 | ÷ | 23.15 | 23.15 | = | 22,667 | ÷ | 979,301,627 | |
| Feb 27, 2009 | 2.48 | = | 48.93 | ÷ | 19.72 | 19.72 | = | 20,386 | ÷ | 1,033,964,089 | |
| Feb 28, 2008 | 2.77 | = | 45.53 | ÷ | 16.43 | 16.43 | = | 17,869 | ÷ | 1,087,627,536 | |
| Feb 28, 2007 | 3.96 | = | 64.26 | ÷ | 16.24 | 16.24 | = | 18,964 | ÷ | 1,167,458,942 | |
| Mar 10, 2006 | 4.26 | = | 73.49 | ÷ | 17.26 | 17.26 | = | 20,451 | ÷ | 1,184,633,787 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Amgen Inc. Annual Report.
Comparison to Competitors
Amgen Inc., P/BV, long-term trends, comparison to competitors
| Amgen Inc. | AbbVie Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2024 | 24.94 | 29.97 | 3.35 | 3.47 | 65.80 | 4.01 | 5.48 | 8.68 | 2.66 | 1.75 | 3.96 | 4.57 |
| Feb 9, 2023 | 35.01 | 15.52 | 4.88 | 3.64 | 29.36 | 4.90 | 5.37 | 6.07 | 2.81 | 2.48 | 3.77 | 4.83 |
| Feb 16, 2022 | 18.51 | 16.53 | 4.07 | 4.16 | 25.28 | 3.65 | 5.90 | 5.05 | 4.31 | 3.35 | 3.60 | 5.18 |
| Feb 9, 2021 | 14.53 | 14.18 | 3.55 | 3.93 | 35.07 | 4.33 | 6.72 | 7.46 | 24.16 | 2.98 | 4.81 | 5.15 |
| Feb 12, 2020 | 13.84 | — | 2.80 | 3.72 | 51.67 | 3.93 | 6.61 | 7.83 | 8.21 | 3.00 | 3.79 | 4.16 |
| Feb 13, 2019 | 9.41 | — | 5.89 | 2.80 | 12.87 | 3.89 | 6.08 | 7.79 | 4.29 | 3.80 | 5.07 | 3.75 |
| Feb 13, 2018 | 5.02 | 36.95 | 8.88 | 2.58 | 7.33 | 5.15 | 5.79 | 4.30 | — | 2.94 | 5.66 | 3.30 |
| Feb 14, 2017 | 4.14 | 21.24 | 5.66 | 2.56 | 6.33 | 4.88 | 4.72 | 4.51 | — | 3.40 | 8.58 | 2.86 |
| Feb 16, 2016 | 3.94 | 22.17 | 7.04 | 2.53 | 5.51 | 6.59 | 4.07 | 3.15 | — | 2.84 | 10.53 | 2.42 |
| Feb 19, 2015 | 4.59 | 56.09 | 6.72 | 2.63 | 5.14 | 10.08 | 4.01 | 3.42 | — | 2.95 | 16.22 | 2.51 |
| Feb 24, 2014 | 4.30 | 18.05 | 5.92 | 2.38 | 3.69 | 11.36 | 3.50 | 3.35 | — | 2.69 | 16.74 | 2.90 |
| Feb 27, 2013 | 3.57 | 18.06 | 4.40 | 2.23 | 4.15 | 7.01 | 3.29 | 2.44 | — | 2.42 | 12.91 | 1.72 |
| Feb 29, 2012 | 2.83 | — | 3.50 | 2.17 | 3.35 | 5.08 | 3.13 | 2.14 | — | 1.95 | 19.19 | 1.38 |
| Feb 25, 2011 | 2.04 | — | 2.76 | 2.39 | 3.21 | 5.29 | 2.88 | 1.85 | — | 1.75 | 6.42 | 1.41 |
| Mar 1, 2010 | 2.46 | — | 2.88 | 2.07 | 4.17 | 6.74 | 3.45 | 1.97 | — | 1.57 | 5.49 | 1.29 |
| Feb 27, 2009 | 2.48 | — | 3.29 | 1.69 | 5.01 | 9.83 | 3.56 | 2.72 | — | 1.44 | 2.94 | 1.02 |
| Feb 28, 2008 | 2.77 | — | 4.22 | 2.62 | 4.16 | 11.76 | 4.17 | 5.38 | — | 2.32 | 3.24 | 1.62 |
| Feb 28, 2007 | 3.96 | — | 5.50 | 3.32 | 5.43 | 18.07 | 4.78 | 5.45 | — | 2.49 | 5.77 | 1.38 |
| Mar 10, 2006 | 4.26 | — | 4.00 | 3.78 | 5.85 | 9.18 | 4.66 | 4.30 | — | 2.94 | 8.16 | 2.03 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Amgen Inc., P/BV, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Amgen Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 14, 2024 | 24.94 | 6.66 |
| Feb 9, 2023 | 35.01 | 5.54 |
| Feb 16, 2022 | 18.51 | 5.66 |
| Feb 9, 2021 | 14.53 | 6.13 |
| Feb 12, 2020 | 13.84 | 5.74 |
| Feb 13, 2019 | 9.41 | 5.93 |
| Feb 13, 2018 | 5.02 | 5.04 |
| Feb 14, 2017 | 4.14 | 4.52 |
| Feb 16, 2016 | 3.94 | 4.10 |
| Feb 19, 2015 | 4.59 | 4.40 |
| Feb 24, 2014 | 4.30 | 3.93 |
| Feb 27, 2013 | 3.57 | 3.19 |
| Feb 29, 2012 | 2.83 | 2.53 |
| Feb 25, 2011 | 2.04 | 2.23 |
| Mar 1, 2010 | 2.46 | 2.35 |
| Feb 27, 2009 | 2.48 | 2.58 |
| Feb 28, 2008 | 2.77 | 3.41 |
| Feb 28, 2007 | 3.96 | 3.81 |
| Mar 10, 2006 | 4.26 | 3.98 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Amgen Inc., P/BV, long-term trends, comparison to industry (health care)
| Amgen Inc. | Health Care | |
|---|---|---|
| Feb 14, 2024 | 24.94 | 5.13 |
| Feb 9, 2023 | 35.01 | 71,951.01 |
| Feb 16, 2022 | 18.51 | 4.78 |
| Feb 9, 2021 | 14.53 | 4.66 |
| Feb 12, 2020 | 13.84 | 4.41 |
| Feb 13, 2019 | 9.41 | 4.42 |
| Feb 13, 2018 | 5.02 | 4.25 |
| Feb 14, 2017 | 4.14 | 3.83 |
| Feb 16, 2016 | 3.94 | 3.47 |
| Feb 19, 2015 | 4.59 | 3.90 |
| Feb 24, 2014 | 4.30 | 3.30 |
| Feb 27, 2013 | 3.57 | 2.70 |
| Feb 29, 2012 | 2.83 | 2.38 |
| Feb 25, 2011 | 2.04 | 2.11 |
| Mar 1, 2010 | 2.46 | 2.23 |
| Feb 27, 2009 | 2.48 | 2.42 |
| Feb 28, 2008 | 2.77 | 3.26 |
| Feb 28, 2007 | 3.96 | 3.75 |
| Mar 10, 2006 | 4.26 | 3.89 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).